Table 2 Detection of antibodies against mallein by means of serological assays over a period of 19 weeks
From: Prevalence-dependent use of serological tests for diagnosing glanders in horses
CFT | iELISA | cELISA | CFT | iELISA | cELISA | CFT | iELISA | cELISA | CFT | iELISA | cELISA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group V | ccPro/ Dubai7 | Dubai7 | Dubai7/ 3D11 | ccPro/ Dubai7 | Dubai7 | Dubai7/ 3D11 | ccPro/ Dubai7 | Dubai7 | Dubai7/ 3D11 | ccPro/ Dubai7 | Dubai7 | Dubai7/ 3D11 |
horse | Day 0 | Day 17 | Day 42 | Day 134 | ||||||||
1 | - | - | - | + | + | - | + | + | - | - | - | - |
2 | - | - | - | + | - | - | - | + | - | - | - | - |
3 | - | - | - | - | - | - | + | - | - | - | - | - |
4 | - | - | - | + | + | + | + | - | - | - | - | |
5 | - | - | - | + | - | - | - | - | - | - | - | - |
6 | - | - | - | + | - | - | + | - | - | - | - | - |
7 | - | - | - | + | - | + | + | - | - | - | - | - |
8 | - | - | - | + | - | + | + | - | - | - | - | - |
9 | - | - | - | + | + | - | + | - | - | - | - | - |
10 | - | - | - | - | - | - | - | - | - | - | - | - |
11 | - | - | - | - | - | - | + | - | - | + | - | - |
12 | - | - | - | + | + | + | + | - | - | - | - | - |
13 | - | - | - | + | - | - | + | - | - | - | - | - |
14 | - | - | - | + | - | - | - | - | - | - | - | - |
15 | - | - | - | + | - | - | + | - | - | - | - | - |
16 | - | - | - | - | - | - | - | - | - | - | - | - |
17 | - | - | - | - | - | - | - | - | - | - | - | - |
18 | - | - | - | + | - | + | - | - | - | - | - | - |
19 | - | - | - | + | - | - | - | - | - | 1:2 | - | - |
20 | - | - | - | - | + | - | - | - | - | - | - | - |
21 | - | - | - | + | + | - | + | - | - | - | - | - |
22 | - | - | - | + | + | + | - | + | + | 1:2 | + | + |
23 | - | - | - | + | - | - | + | - | - | - | - | - |
24 | - | - | - | + | + | - | - | - | - | - | - | - |
25 | - | - | - | - | - | - | - | - | - | - | - | - |